Director Curtis Rosebraugh resigns from Ensysce Biosciences board

Ensysce Biosciences, Inc.

Resignation effective April 1, 2026; no reason given in notice.
Rosebraugh served on the Nominating and Corporate Governance Committee until resignation.
Resignation notice filed as Exhibit 17 to the 8-K.
No replacement announced at this time.

item 5.02 item 9.01

Ensysce Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-015139

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.